Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature - Bertin Instruments

    Scientific publications

    Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature

    Audrey De Rocca Serra-Nédéleca,b, Thomas Edouardc, Karine Tréguera,1, Mylène Tajana,1, Toshiyuki Arakid, Marie Dancee, Marianne Musf, Alexandra Montagnerg, Maïté Tauberc, Jean-Pierre Sallesf, Philippe Valeta, Benjamin G. Neeld, Patrick Raynalb, and Armelle Yarta,2
    Sources: 1. a Institut National de la Santé et de la Recherche Médicale U1048 and Université Paul Sabatier, Institut des Maladies Métaboliques et Cardiovasculaires, F-31432 Toulouse, France; 2. b EA 4568, Université Paul Sabatier, F-31000 Toulouse, France; 3. c Department of Endocrinology, Children's Hospital, F-31000 Toulouse, France; 4. d Campbell Family Cancer research, Institute, Ontario Cancer Institute, University of Toronto, Toronto, ON, Canada M5G 2M9; 5. e Laboratoire de Biologie Moléculaire Eucaryote, Université Paul Sabatier, F-31000 Toulouse, France; 6. f Institut National de la Santé et de la Recherche Médicale U1043 and Université Paul Sabatier, F-31059 Toulouse, France; and 7. g Institut National de la Recherche Agronomique, Toxalim Unit, F-31027 Toulouse, France
    Published online before print February 27, 2012, doi: 10.1073/pnas.1119803109 PNAS February 27, 2012

    Sample name

    Animal tissues (mouse liver)

    ANY QUESTIONS? CONTACT AN EXPERT

    Please fill in this form if you wish to contact our sales team or receive further information.

    My Account
    Forgot password ?

    Add a question !

    Add a question